Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer
January 08, 2020 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2020 and Recent Developments
December 09, 2019 16:05 ET | Avid Bioservices, Inc
-- Achieved Strong Second Quarter Revenue of $18.3 Million and Gross Margin of 18% -- -- Fiscal 2020 Projected Revenue of $64 to $67 Million Reaffirmed -- -- Launched Expanded Process Development...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
December 04, 2019 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Names Richard Richieri as Chief Operations Officer
October 09, 2019 12:30 ET | Avid Bioservices, Inc
TUSTIN, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Completion of Expansion of Process Development Capabilities and Laboratory Infrastructure
October 08, 2019 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Termination of Stockholder Rights Plan
September 23, 2019 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Announces Appointment of Catherine Mackey, Ph.D. to Board of Directors
July 26, 2019 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., July 26, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent Developments
June 27, 2019 16:05 ET | Avid Bioservices, Inc
 -- Achieved Fourth Quarter Revenue of $17.1 Million, an Increase of 146% Compared to Prior Year Quarter -- -- Generated Income From Continuing Operations During the Fourth Quarter of Fiscal 2019 -- ...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices To Report Financial Results For Third Quarter Of Fiscal Year 2019 After Market Close On March 11, 2019
March 04, 2019 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2019 and Recent Developments
December 10, 2018 16:05 ET | Avid Bioservices, Inc
-- Fiscal 2019 Projected Revenue of $51 to $55 Million Reaffirmed -- -- Signed Project Expansion Orders for $6.3 Million with Current Customers -- -- Successfully Executed Scheduled Broad Scale...